|
The supplement
Lyprinol® appears to be effective in treating pain and in
increasing the mobility of patients suffering from osteoarthritis,
according to a study reported in the journal Progress in Nutrition.
Lyprinol
is a marine lipid extract derived from the New Zealand green-lipped mussel.
The placebo-controlled,
double-blind trial involved 80 patients with knee osteoarthritis
and was conducted between 2001 and 2003 at Queen Mary Hospital
in Hong Kong. The participants were given either Lyprinol or a
placebo for six months.
After
four weeks, patients who received Lyprinol experienced less pain and scored higher
on standard measures for physical function than those receiving a placebo. When
used over six months, Lyprinol® was found to be safe and well tolerated with
no serious side effects reported. Lead
researcher C.S. Lau, the co-chief of the division of Rheumatology at the University
of Hong Kong, concluded that Lyprinol might be considered a safe option in the
treatment of osteoarthritis. Other
sources: University of Hong Kong
|